Comparing your progress to others is counterproductive because genetic factors, baseline metabolism, and initial weight all influence how quickly individual results appear
Macrophage metabolism as therapeutic target for cancer, atherosclerosis, and obesity
Sulas, P., et al., Alpha-lipoic acid promotes the growth of rat hepatic pre-neoplastic lesions in the choline-deficient model
We do have: 10+ year safety data for earlier GLP-1 agonists (liraglutide, exenatide) Growing evidence of cardiovascular benefits from weight loss medications Understanding that obesity itself has well-documented health risks The risk-benefit calculation often favors treatment, but this is an individual decision that should be made with your healthcare provider based on your specific medical situation
"We're at a point where we need to hold two truths: That GLP-1s are legitimate evidence-based treatments for obesity, but that they also sit inside our culture, which has intense weight pressure, weight stigma and eating disorder risk," she says
